Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-06

Clinical Trial Update: Evaluation of Articaine 4% Versus Mepivacaine 2% for Surgery of Molars Thirds: Clinical Trial. [NA]

View source ↗

Summary

Completed clinical trial comparing articaine 4% versus mepivacaine 2% for anesthesia in third molar surgery, including cases with impacted teeth.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Articaine (articaine)
  • Mepivacaine (mepivacaine)

Snippet

Sponsor: Universidade Estadual Paulista Júlio de Mesquita Filho | Conditions: Pain, Teeth, Impacted | NA | Status: COMPLETED